Cortechs.ai | Evaluating the Individual with the Power of Many: Using Normative Data in Personalized Medicine

Evaluating the Individual with the Power of Many: Using Normative Data in Personalized Medicine

When evaluating a subject’s brain structure volumes, looking at absolute volumes is the first step. However, naturally occurring variances due to age or gender might distort the impression these values provide. Differences in overall head size might distort the impression further, and result in questions such as: Is this hippocampus exceptionally small or is my patient’s overall brain size small and the smaller hippocampus is expected for somebody their age?

Normalizing the brain structure to the intracranial volume (ICV) adjusts for differences in overall head size; further restrictions of comparison to male and female subjects of a defined age provides even better results.

Cortechs.ai | Evaluating the Individual with the Power of Many: Using Normative Data in Personalized Medicine

Using a normative data set established out of large population data gives context to the personalized brain structure volumes over a very broad age range. The WHO and CDC have been using normative reference charts for growth evaluations in children for many years. The same approach is used in the visualization of NeuroQuant®, results displaying an individual’s brain structure volume measurements relative to a healthy population. This allows NeuroQuant to deliver a precise impression of where that individual’s brain structure volume lies within an age- and gender- based reference chart, which aids physicians in their assessment of neurodegenerative conditions.

Cortechs.ai | Evaluating the Individual with the Power of Many: Using Normative Data in Personalized Medicine

Displaying the normalized patient brain structure volumes with reference to healthy cohorts based on age and gender is an integral part of NeuroQuant and a feature of each NeuroQuant report. Since launch in 2007, the NeuroQuant normative database has been continuously tested and validated against tens of thousands of clinical cases.

Want to learn more about Cortechs.ai Normative Database? Cortechs.ai has developed a Normative Database white paper, which is now available for download.

More Resources

02/25/2026

Cortechs.ai Announces MFDS (KFDA) Approval of Global-Leading NeuroQuant® V5 Platform in South Korea

MFDS approves NeuroQuant® V5 in South Korea, expanding AI-driven volumetric neuroimaging and clinical decision support.

02/24/2026

Financial Conflict Of Interest Policy Applicable To NIH Awards

02/20/2026

NeuroQuant® PET: FDA 510(k)-Pending Advancement in Molecular Dementia Imaging

FDA 510(k)-Pending NeuroQuant® PET delivers automated, standardized quantification for amyloid, tau, and FDG imaging in dementia care.

02/19/2026

How Cortechs.ai Protects ePHI: HIPAA‑Aligned Controls—and Beyond

Cortechs.ai’s HIPAA-aligned, defense-in-depth security safeguards ePHI across AI workflows—exceeding baseline compliance standards.

02/11/2026

NeuroQuant Normative Database: Advancing Age‑ and Sex‑Specific Brain Volumetry

Learn how the latest updates to the NeuroQuant normative database white paper strengthen age- and sex-specific brain volumetry and enhance clinical confidence.

02/06/2026

NeuroQuant Normative Database: A Standard for Age- and Sex-Specific Brain Volumetry

Whitepaper: How Cortechs.ai’s normative database was created to accurately compare an individual’s brain structure volume to a healthy population.
Scroll to Top